Clinical Trial Update: Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders

View source ↗

Summary

A completed clinical trial studied paroxysmal hyperkinetic movement disorders using SPECT imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkinetic Movement Disorders

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Hyperkinesis | Status: COMPLETED